TikoMed AB gets Orphan Drug Designation
July 27th, 2011
No comments
FDA grants TM-400 Orphan Drug Designation for “Mobilization of Stem Cells Used to Treat Hematologic Cancer” in the US which follows EU designation Read more…
Categories: Orphan Drug Designation (ODD), TikoMed AB
